Celldex Therapeutics Inc (CLDX)
27.78
-0.22 -0.79%
NASDAQ
Jun 18, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 5.374M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.83 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -63.69M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -2.41K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 1.100B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 181.73 |
| PE Ratio | -- |
| Price to Book Value | 5.668 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -18.65M |
| Return on Equity | Upgrade |
View All CLDX News
News
-
WireHeadlineTime (ET)
-
SA Breaking News06/14 16:55
-
Globe Newswire06/04 09:01
-
Globe Newswire06/01 07:31
-
Globe Newswire05/26 16:01
-
Yahoo05/13 03:18
-
Yahoo05/06 18:35
-
SA Breaking News05/06 17:03
-
MT Newswires05/06 16:09
-
MT Newswires05/06 16:09
-
Globe Newswire05/06 16:01
-
Yahoo04/20 11:56
-
Globe Newswire04/12 16:01
-
Yahoo04/10 06:13
-
Yahoo04/06 09:05
-
MT Newswires03/29 16:18
-
SA Breaking News03/29 16:07
-
MT Newswires03/29 16:04
-
MT Newswires03/29 16:04
-
Globe Newswire03/29 16:01
-
MT Newswires03/29 14:59
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/06/2021 16:30 EST | Earnings Calls | Q2 2021 Earnings Call |
| 08/06/2021 | Earnings Results | Q2 2021 Earnings Results |
| 06/17/2021 09:00 EST | AGM | 2020 Annual General Meeting |
| 05/06/2021 | Earnings Results | Q1 2021 Earnings Results |
| 03/29/2021 | Earnings Results | Q4 2020 Earnings Results |
| 11/05/2020 | Earnings Results | Q3 2020 Earnings Results |
| 08/06/2020 16:30 EST | Earnings Calls | Q2 2020 Earnings Call |
| 08/06/2020 | Earnings Results | Q2 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
- URL: https://www.celldex.com
- Investor Relations URL: https://ir.celldex.com
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 06, 2021
- Last Earnings Release: May. 06, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 27.78 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| ETCHX | Eventide Healthcare & Life Sciences C | 1.93% |
| LYFCX | AlphaCentric LifeSci Healthcare C | 1.85% |
| MOPRX | MainStay WMC Small Companies R1 | 1.72% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
